Skip to main content

© 2026 Verity by Backwork. All rights reserved.

Q5117 - HCPCS Level II | Verity

Home/Codes/HCPCS Level II/Q5117

HCPCS Level IItemporaryActive

Q5117

Inj., kanjinti, 10 mg

BETOS: O1E

Effective: 2019-10-01

Description

Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg

Drug Products

FDA-registered drug products mapped to this HCPCS code

KANJINTI (PF,LYOPHILIZED) 420 MG

NDC: 55513-0132-01IV

Billing: EA

KANJINTI (SDV,PF,LATEX-FREE) 150 MG

NDC: 55513-0141-01IV

Billing: EA

KANJINTI KIT (W/DILUENT,PF) 420 MG

NDC: 55513-0164-01IV

Billing: EA

Sign up to see all NDC products and conversion factors for this code.

Medicare Fee Schedule

2026 Medicare Physician Fee Schedule national payment rates

Excluded

This code is excluded from the Medicare Physician Fee Schedule.

Coverage Policies

No coverage policies currently reference this code

This code is not currently listed in any LCD or NCD coverage policies in our database.

About HCPCS Level II

Healthcare Common Procedure Coding System Level II codes for supplies, equipment, and non-physician services

Unlock Full Coverage Intelligence

See which policies cover this code, disposition status, and coverage criteria

Sign Up Free Already have an account? Log in

What You Get with Verity

✓Coverage policy linkage
✓Disposition status per policy
✓Full coverage criteria text
✓Policy change alerts
✓API access for integrations

Browse More Codes

HCPCS Codes ICD-10-CM Diagnosis Codes ICD-10-PCS Procedure Codes